This site is supported by
The Consequences of Antimicrobial Misuse
According to the World Health Organization (WHO), there are no global data on the number of cases or fatalities due to highly resistant pathogens. These gaps in knowledge regarding the economic and human cost of resistant bacterial infections are due to the lack of any coordinated global surveillance system. In the U.S. alone, superbugs affect more than 2 million individuals and contribute to 99,000 deaths each year.1 In the European Union, at least 25,000 patients die every year from multidrug-resistant pathogens2; two-thirds of these are due to gram-negatives. Once confined almost exclusively to the hospital environment, superbugs such as MRSA and Clostridium difficile are now emerging in the community setting.
- Center for Disease Dynamics, Economics & Policy (CDDEP) (2013) Unstoppable Superbugs: Closer than We Think? [Video] Date accessed: 06/21/2013 http://youtu.be/rIfvLp1YHmE
- World Health Organization (WHO) (2011) Race Against Time to Develop New Antibiotics Bulletin. Date accessed: 06/21/2013 http://www.who.int/bulletin/volumes/89/2/11-030211/en/
Copyright © 2014 Alliance for the Prudent Use of Antibiotics (APUA), licensed to Alere Inc.